NANOBIOTIX (Euronext: NANO –– NASDAQ: NBTX – the ‘‘Company’’), a late-stage clinical biotechnology company pioneering physics ...

He's also a sought-after industry speaker and panelist on topics including AI and communications technology, crisis ...

While the investment has been welcomed in Cambridge, some said there are still questions that need answering over exactly how ...

Cambridge City Council candidates gathered at the Science Center on Tuesday to pitch their policies on housing, transportation, and relations with the federal government in the final stretch before ...

When students entered Tsinghua University in Beijing this year, one of the first representatives they met wasn’t a person.

Title: Cancer Research UK first-in-human (FIH) phase I/IIa trial of the prostaglandin E2 (PGE2) receptor 4 (EP4) antagonist HTL0039732 (HTL) as monotherapy and in combination with immunotherapy in ...

A new study led by the University of Oxford, in collaboration with Yale and Cambridge, suggests that even small amounts of ...

It is the start of the academic year at Cambridge and the streets are busy with students of every description imaginable, ...

The findings suggest that the acquisition of the modern NOVA1 variant may have protected us from the detrimental effects of ...

South Korea’s AI learning program was rolled back after just four months following a backlash from teachers, students, and ...

Sex cells made from scratch could revolutionize human reproduction. But researchers are struggling to translate promising ...